Skip to main content
SpringerLink
Log in

The Pathology of Systemic Fibroinflammatory Disorders

  • Chapter
  • First Online:
Book cover Systemic Fibroinflammatory Disorders

Part of the book series: Rare Diseases of the Immune System ((RDIS))

  • 685 Accesses

Abstract

The broad denomination of “systemic fibroinflammatory disorders” includes a series of exceedingly different lesions whose common morphologic characteristic is a local deposition of varying amounts of fibrous tissue and inflammatory infiltrates. From a histopathological standpoint, the main consequence of such a feature is the fact that the morphofunctional architecture of a given parenchyma (or complex structure) is partially or totally replaced by nonfunctioning tissues. This fact is especially critical in multifocal systemic disorders and, what’s more, in cases characterized by particular aggressiveness, as in neoplastic fibroinflammatory diseases. A further point to be highlighted is the relative slow turnover of the above-mentioned newly formed tissues, first and foremost fibrosis. This fact makes most of clinical treatments scarcely effective in helping to induce restitutio ad integrum of the affected anatomical locations.

In this chapter, we have described the pathology of most of the fibroinflammatory disorders which are clinically discussed in the present textbook. The biological nature and pathogenesis of these lesions is highly different, ranging from still barely known diseases to iatrogenic disorders, autoimmune diseases, vasculitic forms, or neoplastic lesions.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Emory TS, Monihan JM, Carr NJ, Sobin LH (1997) Sclerosing mesenteritis, mesenteric panniculitis and mesenteric lipodystrophy: a single entity? Am J Surg Pathol 21:392–398

    Article  CAS  PubMed  Google Scholar 

  2. Weaver J, Goldblum JR, Turner S, Tubbs RR, Wang WL, Lazar AJ et al (2009) Detection of MDM2 gene amplification or protein expression distinguishes sclerosing mesenteritis and retroperitoneal fibrosis from inflammatory well-differentiated liposarcoma. Mod Pathol 22:66–70

    Article  CAS  PubMed  Google Scholar 

  3. Bernstein EJ, Schmidt-Lauber C, Kay J (2012) Nephrogenic systemic fibrosis: a systemic fibrosing disease resulting from gadolinium exposure. Best Pract Res Clin Rheumatol 26:489–503

    Article  CAS  PubMed  Google Scholar 

  4. Levine JM, Taylor RA, Elman LB, Bird SJ, Lavi E, Stolzenberg ED et al (2004) Involvement of skeletal muscle in dialysis-associated systemic fibrosis (nephrogenic fibrosing dermopathy). Muscle Nerve 30:569–577

    Article  PubMed  Google Scholar 

  5. Kribben A, Witzke O, Hillen U, Barkhausen J, Daul AE, Erbel R (2009) Nephrogenic systemic fibrosis: pathogenesis, diagnosis, and therapy. J Am Coll Cardiol 53:1621–1628

    Article  CAS  PubMed  Google Scholar 

  6. Girardi M, Kay J, Elston DM, Leboit PE, Abu-Alfa A, Cowper SE (2011) Nephrogenic systemic fibrosis: clinicopathological definition and workup recommendations. J Am Acad Dermatol 65:1095–1106.e7

    Article  PubMed  Google Scholar 

  7. Kamisawa T, Zen Y, Pillai S, Stone JH (2015) IgG4-related disease. Lancet 385:1460–1471

    Article  CAS  PubMed  Google Scholar 

  8. Khosroshahi A, Wallace ZS, Crowe JL, Akamizu T, Azumi A, Carruthers MN et al (2015) International Consensus Guidance Statement on the management and treatment of IgG4-related disease. Arthritis Rheumatol 67:1688–1699

    Article  CAS  PubMed  Google Scholar 

  9. Deshpande V, Zen Y, Chan JK, Yi EE, Sato Y, Yoshino T et al (2012) Consensus statement on the pathology of IgG4-related disease. Mod Pathol 25:1181–1192

    Article  PubMed  Google Scholar 

  10. Stone JR (2011) Aortitis, periaortitis, and retroperitoneal fibrosis, as manifestations of IgG4-related systemic disease. Curr Opin Rheumatol 23:88–94

    Article  CAS  PubMed  Google Scholar 

  11. Corradi D, Nicastro M, Vaglio A (2016) Immunoglobulin G4-related disease: some missing pieces in a still unsolved complex puzzle. Cardiovasc Pathol

    Google Scholar 

  12. Corradi D, Maestri R, Palmisano A, Bosio S, Greco P, Manenti L et al (2007) Idiopathic retroperitoneal fibrosis: clinicopathologic features and differential diagnosis. Kidney Int 72:742–753

    Article  CAS  PubMed  Google Scholar 

  13. Urban ML, Palmisano A, Nicastro M, Corradi D, Buzio C, Vaglio A (2015) Idiopathic and secondary forms of retroperitoneal fibrosis: a diagnostic approach. Rev Med Interne 36:15–21

    Article  CAS  PubMed  Google Scholar 

  14. Riedel B (1896) Die chronische, zur Bildung eisenharter Tumoren führende Entzündung der Schilddrüse. Verh Dtsch Ges Chir 25:101–105

    Google Scholar 

  15. Papi G, Corrado S, Carapezzi C, De Gaetani C, Carani C (2003) Riedel’s thyroiditis and fibrous variant of Hashimoto’s thyroiditis: a clinicopathological and immunohistochemical study. J Endocrinol Invest 26:444–449

    Article  CAS  PubMed  Google Scholar 

  16. Hashimoto H (1912) Zur Kenntnis der Lymphomatosen Veranderungen der Schilddruse (Struma Lymphomatosa). Arch Klin Chir 97:219

    Google Scholar 

  17. Fisher DA, Oddie TH, Johnson DE, Nelson JC (1975) The diagnosis of Hashimoto’s thyroiditis. J Clin Endocrinol Metab 40:795–801

    Article  CAS  PubMed  Google Scholar 

  18. Katz SM, Vickery AL Jr (1974) The fibrous variant of Hashimoto’s thyroiditis. Hum Pathol 5:161–170

    Article  CAS  PubMed  Google Scholar 

  19. Li Y, Zhou G, Ozaki T, Nishihara E, Matsuzuka F, Bai Y et al (2012) Distinct histopathological features of Hashimoto’s thyroiditis with respect to IgG4-related disease. Mod Pathol 25:1086–1097

    Article  PubMed  Google Scholar 

  20. Li Y, Bai Y, Liu Z, Ozaki T, Taniguchi E, Mori I et al (2009) Immunohistochemistry of IgG4 can help subclassify Hashimoto’s autoimmune thyroiditis. Pathol Int 59:636–641

    Article  CAS  PubMed  Google Scholar 

  21. Chester W (1930) Uber lipoidgranulomatose. Virchows Arch Pathol Anat 279:561–602

    Article  Google Scholar 

  22. Haroche J, Arnaud L, Amoura Z (2011) Erdheim-Chester disease. Curr Opin Rheumatol 24:53–59

    Article  Google Scholar 

  23. Jaffe R (2013) Erdheim-Chester disease. In: Fletcher C, Bridge J, Hogendoorn P, Mertens F (eds) WHO classification of tumours of soft tissue and bone. IARC Press, Lyon, pp 358–359

    Google Scholar 

  24. Lieberman PH, Jones CR, Steinman RM, Erlandson RA, Smith J, Gee T et al (1996) Langerhans cell (eosinophilic) granulomatosis. A clinicopathologic study encompassing 50 years. Am J Surg Pathol 20:519–552

    Article  CAS  PubMed  Google Scholar 

  25. Weiss L, Dura T, Grogan T, Favara B, Müller-Hermelink H, Paulli M et al (2001) Langerhans cell histiocytosis. In: Jaffe E, Harris N, Stein H, Vardiman J (eds) Pathology & genetics tumours of haematopoietic and lymphoid tissues. IARC Press, Lyon, pp 280–282

    Google Scholar 

  26. Rosai J, Dorfman RF (1969) Sinus histiocytosis with massive lymphadenopathy. A newly recognized benign clinicopathological entity. Arch Pathol 87:63–70

    CAS  PubMed  Google Scholar 

  27. Dalia S, Sagatys E, Sokol L, Kubal T (2014) Rosai-Dorfman disease: tumor biology, clinical features, pathology, and treatment. Cancer Control 21:322–327

    PubMed  Google Scholar 

  28. Foucar E, Rosai J, Dorfman R (1990) Sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease): review of the entity. Semin Diagn Pathol 7:19–73

    CAS  PubMed  Google Scholar 

  29. Zhao M, Li C, Zheng J, Yu J, Sha H, Yan M et al (2013) Extranodal Rosai-Dorfman disease involving appendix and mesenteric nodes with a protracted course: report of a rare case lacking relationship to IgG4-related disease and review of the literature. Int J Clin Exp Pathol 6:2569–2577

    PubMed  PubMed Central  Google Scholar 

  30. Weiss L, Dura T, Grogan T, Favara B, Müller-Hermelink H, Paulli M et al (2001) Follicular dendritic cell sarcoma/tumour. In: Jaffe E, Harris N, Stein H, Vardiman J (eds) Pathology & genetics tumours of haematopoietic and lymphoid tissues. IARC Press, Lyon, pp 286–288

    Google Scholar 

  31. Pileri SA, Grogan TM, Harris NL, Banks P, Campo E, Chan JK et al (2002) Tumours of histiocytes and accessory dendritic cells: an immunohistochemical approach to classification from the International Lymphoma Study Group based on 61 cases. Histopathology 41:1–29

    Article  CAS  PubMed  Google Scholar 

  32. Weiss L, Dura T, Grogan T, Favara B, Müller-Hermelink H, Paulli M et al (2001) Histiocytic sarcoma. In: Jaffe E, Harris N, Stein H, Vardiman J (eds) Pathology & genetics tumours of haematopoietic and lymphoid tissues. IARC Press, Lyon, pp 278–279

    Google Scholar 

  33. Hornick J (2013) Soft tissue tumors with prominent inflammatory cells. In: Hornick J (ed) Practical soft tissue pathology a diagnostic approach. Elsevier – Saunders, Philadelphia, pp 253–277

    Google Scholar 

  34. Coffin C, Fletcher J (2013) Inflammatory myofibroblastic tumour. In: Fletcher C, Bridge J, Hogendoorn P, Mertens F (eds) WHO classification of tumours of soft tissue and bone, 4th edn. IARC Press, Lyon, pp 83–84

    Google Scholar 

  35. Coffin CM, Hornick JL, Fletcher CD (2007) Inflammatory myofibroblastic tumor: comparison of clinicopathologic, histologic, and immunohistochemical features including ALK expression in atypical and aggressive cases. Am J Surg Pathol 31:509–520

    Article  PubMed  Google Scholar 

  36. Coffin CM, Watterson J, Priest JR, Dehner LP (1995) Extrapulmonary inflammatory myofibroblastic tumor (inflammatory pseudotumor). A clinicopathologic and immunohistochemical study of 84 cases. Am J Surg Pathol 19:859–872

    Article  CAS  PubMed  Google Scholar 

  37. Gleason BC, Hornick JL (2008) Inflammatory myofibroblastic tumours: where are we now? J Clin Pathol 61:428–437

    Article  CAS  PubMed  Google Scholar 

  38. Marino-Enriquez A, Wang WL, Roy A, Lopez-Terrada D, Lazar AJ, Fletcher CD et al (2011) Epithelioid inflammatory myofibroblastic sarcoma: an aggressive intra-abdominal variant of inflammatory myofibroblastic tumor with nuclear membrane or perinuclear ALK. Am J Surg Pathol 35:135–144

    Article  PubMed  Google Scholar 

  39. Cessna MH, Zhou H, Sanger WG, Perkins SL, Tripp S, Pickering D et al (2002) Expression of ALK1 and p80 in inflammatory myofibroblastic tumor and its mesenchymal mimics: a study of 135 cases. Mod Pathol 15:931–938

    Article  PubMed  Google Scholar 

  40. Butrynski JE, D’Adamo DR, Hornick JL, Dal Cin P, Antonescu CR, Jhanwar SC et al (2010) Crizotinib in ALK-rearranged inflammatory myofibroblastic tumor. N Engl J Med 363:1727–1733

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Biomedical, Biotechnological, and Translational Sciences (S.Bi.Bi.T.), Unit of Pathology, University of Parma, Parma, Italy

    Domenico Corradi MD

  2. Nephrology Unit, University Hospital of Parma, Parma, Italy

    Maria Nicastro BsSc

Authors
  1. Domenico Corradi MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Maria Nicastro BsSc
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Domenico Corradi MD .

Editor information

Editors and Affiliations

  1. Department of Nephrology, University Hospital, Parma, Italy

    Augusto Vaglio

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Corradi, D., Nicastro, M. (2017). The Pathology of Systemic Fibroinflammatory Disorders. In: Vaglio, A. (eds) Systemic Fibroinflammatory Disorders. Rare Diseases of the Immune System. Springer, Cham. https://doi.org/10.1007/978-3-319-41349-5_3

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-41349-5_3

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-41347-1

  • Online ISBN: 978-3-319-41349-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation